Promising drugs in clinical development for cystic fibrosis
GlobalData's cystic fibrosis market forecast focuses on five products expected to be licensed in the...
Comment
Covid-related product quality losses cause higher inflation – leading macroeconomic influencers
Covid pandemic-related quality degradations break tricky inflation quality adjustments.
Pregnant women with HHC have limited access to pharmacotherapy
Increased innovation in hereditary haemochromatosis (HHC) could improve treatment options for pregnant women with the...
Global HER2+ breast cancer ADC market to reach $3.3bn by 2030
GlobalData expects HER2+ breast cancer to remain at the heart of innovation for the antibody-drug...
First successful trial in heart failure with preserved ejection fraction
According to the trial results, Jardiance reduces the risk of death or hospitalisation due to...
Emerging markets dip amid Delta variant resurgence – leading macroeconomic influencers
Developed economies outperform emerging markets amid a resurgence of the Covid-19 Delta variant.
Intranasal ketamine could effectively treat phantom pain
Studies suggest that it may be possible for Janssen’s Spravato (esketamine) to be used for the treatment of phantom pain.
Millions of US workers cut off from jobless benefits – leading macroeconomic influencers
Jobless benefits expired for millions of US workers, amid rising infections and a relief plan with inherent biases.
Targeted anti-epileptic therapies could reduce the frequency of SUDEP
Epileptic patients’ individual characteristics are increasingly used to try to avoid sudden unexpected death in epilepsy (SUDEP).
US job market faces massive mismatch – leading macroeconomic influencers
About 8.4 million unemployed alongside 10 million job openings amid a rapidly changing US economy.
Leading regenerative medicine advocacy group leverages GlobalData’s datasets to highlight a record year
The Alliance for Regenerative Medicine’s report reveals the data behind a “year of firsts and records” for the sector.
